SUCRAL O (Sucralfate (1000mg/10ml) + Oxetacaine (10mg/10ml))

Sucral-O SYRUP is a multi-ingredient medication designed to manage symptoms related to stomach acidity, ulcers, and heartburn. It provides relief from discomforts such as stomach pain and irritation caused by excessive acidity and ulcers. By neutralizing the surplus acid in the stomach, this syrup aids in facilitating the passage of gas, thereby relieving discomfort. The administration of Sucral-O SYRUP should be done without food and in a dosage and duration prescribed by a healthcare professional. The specific dose is tailored to your individual needs based on your health condition and response to treatment. It is vital to adhere to the prescribed regimen, as premature discontinuation may lead to a resurgence of symptoms and potential deterioration of your condition. Ensure to inform your healthcare provider about any other medications you are currently taking, as interactions may occur. Additionally, it is crucial not to exceed the recommended duration of use, since prolonged use could result in adverse health effects. Common adverse effects may include constipation, nausea, vomiting, dizziness, insomnia, and allergic reactions. These effects are typically temporary and resolve naturally over time. If you have concerns about side effects, it is important to reach out to your healthcare provider for guidance. To alleviate constipation, increase your intake of fiber-rich foods and maintain proper hydration. Caution is advised regarding activities requiring mental focus, such as driving, particularly if you experience dizziness or drowsiness. Avoid alcohol consumption during the treatment period, as it may exacerbate sedation. Making dietary adjustments, such as consuming cold milk and steering clear of hot beverages, spicy foods, and chocolate, can contribute to improved results. Prior to starting this medication, it is essential to discuss any pregnancy plans, existing pregnancy, or breastfeeding status with your doctor. Additionally, those with liver conditions should inform their healthcare provider for appropriate dosage adjustments.